The Centre has invested in developing a strain specific vaccine that would help in countering the changing nature of coronavirus. An official who facilitated developing this ecosystem for second generation vaccines told India Today that research and development work is underway to develop strain-specific vaccines in India. A bivalent vaccine will target the specific spike mutations seen in the Omicron …
"BBIL has successfully commercialised a universal COVID-19 vaccine for adults and children. The University of Sydney will provide a framework for pre-clinical assessment of vaccine candidates, together with access to Australia's world-class early phase clinical trial community," said Professor James Triccas, Sydney Institute for Infectious Diseases, The University of Sydney. "Our technological platform for innovative protein designs was used in …